Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ondansetron (zofran) (1 trial)
propofol (diprivan) (1 trial)
cd19 car-t cells (1 trial)
dornase alfa (pulmozyme) (1 trial)
platelet-rich plasma (4 trials)
umbilical cord mesenchymal stem cells (1 trial)
2'-fucosyllactose (1 trial)
duloxetine (Cymbalta) (1 trial)
lavender (1 trial)
methylprednisolone (medrol) (1 trial)
orange oil (1 trial)
tenoxicam (1 trial)
tranexamic acid (cyklokapron) (1 trial)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Skin Diseases (Phase 2)
Trials (15 total)
Trial APIs (13 total)